AzTrials
AzTrials

Childbirth-related Post-traumatic Stress DisorderSSPT-ANCT07827508

Assessment of Childbirth-Related Post-Traumatic Stress Disorder

A study testing City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization in people with Childbirth-related Post-traumatic Stress Disorder, run by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The main objective of this study is to estimate the prevalence of childbirth-related post-traumatic stress disorder (PTSD) among mothers treated at the maternity ward of Emile Muller Hospital (Mulhouse, Haut-Rhin, France). Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,000 participants
Where
1 siteFrance
Study dates
1 Oct 2026to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women aged 18 or older
  • Having given birth in the maternity ward at Emile Muller Hospital (Mulhouse, Haut-Rhin, France)
  • Fluent in French
  • Having provided written consent to participate in the study
  • Being covered by a social security program

Who cannot join

  • Women who gave birth anonymously
  • Women who gave birth to a stillborn child or a fetus that died in utero
  • Women under legal protection (guardianship, conservatorship, judicial protection).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Edgar Yohny Montoya Ramirez, MD contact

+33 3 89 64 64 64

montoyaramireze@ghrmsa.fr

France1 site
  • Groupe Hospitalier de la Région de Mulhouse et Sud Alsace

    Mulhouse, 68100

Other trials in France

About this study

Official title: Assessment of Childbirth-Related Post-Traumatic Stress Disorder: A Single-Center Prospective Study

The main objective of this study is to estimate the prevalence of childbirth-related post-traumatic stress disorder (PTSD) among mothers treated at the maternity ward of Emile Muller Hospital (Mulhouse, Haut-Rhin, France).

Read the detailed description

Secondary objectives

  1. To identify risk factors associated with the development of PTSD, in order to determine which situations-particularly obstetric ones-could lead women to experience trauma, and understand the underlying psychological mechanisms. Risk factors identified in the literature or deemed relevant by the study's clinicians and psychologists will be gathered from medical records.
  2. To assess healthcare utilization in the context of the onset of childbirth-related PTSD from the women's perspective, using a questionnaire consisting of a series of questions about the different healthcare professionals consulted during the month following childbirth.

Conduct of research About one month after giving birth, women who have provided their consent will receive an email containing a personal link to the eCRF page where they will find the French version of the "City Birth Trauma Scale" (CBTS) questionnaire, as well as the questionnaire designed to assess their use of healthcare services.

After completing the CBTS questionnaire, the participant can choose to check a box in the eCRF to indicate whether or not she wishes to be contacted by the research team in the event that her score suggests a diagnosis of PTSD.

If the participant has not completed the questionnaire within 10 days of receiving the link, a follow-up email will be sent to her. If, after receiving this follow-up email, the participant has not completed the questionnaire or contacted the research team, she will be considered lost to follow-up.

Being tested
City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization
Keywords
Parturition, Post Traumatic Stress Disorder, Screening, City Birth Trauma Scale
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilizationDiagnostic test

    About one month after giving birth, patients who have given their consent will receive an email containing a personal link to the eCRF page with the French version of the City Birth Trauma Scale (CBTS) questionnaire, as well as a questionnaire to assess their use of healthcare services.

    After completing the CBTS questionnaire, the participant can choose to check a box in the eCRF to indicate whether or not she wishes to be contacted by the research team in the event that her score suggests a diagnosis of PTSD.

Study groups in NCT07827508
Study groupRoleWhat they receive
Women who have given birth within the past monthOtherNot described
Receives: Diagnostic Test: City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. City Birth Trauma Scale

    The diagnosis of PTSD based on responses to the questionnaire will be made in accordance with the questionnaire's scoring method, which assesses 8 criteria based on the DSM-5 (criteria labeled A through H).

    Measured: About 1 month after childbirth

Secondary outcomes (1)
  1. Questionnaire on the assessment of healthcare utilization

    A ten-item questionnaire to assess the use of healthcare services in the context of postpartum post-traumatic stress disorder from the women's perspective, enquiring about the healthcare professionals these women consulted during the month following childbirth.

    Measured: About 1 month after childbirth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Women who have given birth within the past month
Masking
None (open label)
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07827508
Sponsor's protocol ID
GHRMSA 1497
Other IDs
ID-RCB 2026-A00733-48
Acronym
SSPT-A
Status last verified
Sep 2026
First submitted
14 Sep 2026
Last updated
18 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization in people with Childbirth-related Post-traumatic Stress Disorder, run by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Edgar Yohny Montoya Ramirez, MD (+33 3 89 64 64 64, montoyaramireze@ghrmsa.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

City Birth Trauma Scale (time frame: About 1 month after childbirth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in